Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6109]

SABCS 2016: More complications for breast cancer patients who get radiation, implants

SABCS 2016: More complications for breast cancer patients who get radiation, implants

SABCS 2016: BELLE-3 trial meets primary endpoint of progression-free survival for breast cancer

SABCS 2016: BELLE-3 trial meets primary endpoint of progression-free survival for breast cancer

SABCS 2016: Trial of presurgery abemaciclib treatment for early-stage HR-pos/HER2-neg breast cancer met primary endpoint

SABCS 2016: Trial of presurgery abemaciclib treatment for early-stage HR-pos/HER2-neg breast cancer met primary...

SABCS 2016: Adding ibandronate to hormone therapy did not improve outcomes for postmenopausal breast cancer patients

SABCS 2016: Adding ibandronate to hormone therapy did not improve outcomes for postmenopausal breast cancer...

SABCS 2016: Adding an aromatase inhibitor to presurgery treatment for HR/HER2 positive breast cancer provided no additional benefit

SABCS 2016: Adding an aromatase inhibitor to presurgery treatment for HR/HER2 positive breast cancer provided no...

FDA approves bevacizumab with chemotherapy for platinum-sensitive ovarian cancer

FDA approves bevacizumab with chemotherapy for platinum-sensitive ovarian cancer

Personalised cancer vaccine associated with promising outcomes for AML patients

Personalised cancer vaccine associated with promising outcomes for AML patients

Fat intake shows link to metastasis

Fat intake shows link to metastasis

SABCS 2016 : Adding everolimus to fulvestrant improved outcomes for postmenopausal patients with HR-positive breast cancer

SABCS 2016 : Adding everolimus to fulvestrant improved outcomes for postmenopausal patients with HR-positive...

SABCS 2016 : Adding veliparib to chemotherapy improved response rates among patients with BRCA-mutant breast cancer

SABCS 2016 : Adding veliparib to chemotherapy improved response rates among patients with BRCA-mutant breast cancer

More from ecancer